Market Insights Health Hospitals Inpatient Care

Gastroenterology - Southern Africa

Southern Africa

The Gastroenterology market in Southern Africa is expected to experience significant growth in the coming years.
According to projections, the market is set to reach a revenue of US$0.72bn by 2024.
This growth is expected to continue at an annual growth rate (CAGR 2024-2029) of 1.35%.
By 2029, the market volume is estimated to reach US$0.77bn.
When comparing the revenue generated in the Gastroenterology market globally, it is evident that United States will take the lead.
In 2024, United States is projected to generate a revenue of US$60,480.00m.
This highlights the dominance of the United States in this market.
Southern Africa is experiencing a surge in demand for advanced endoscopic procedures, driving innovation in the gastroenterology market.

Key regions: France, China, Japan, United States, Europe

Market

Region

Region comparison

Currency

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.